OncoTyrol – Center for Personalized Cancer Medicine GmbH

http://www.oncotyrol.at

The K1 project for Personalized Cancer Medicine (OncoTyrol) has a project volume of €28 Mio over the next 4 years. The vision of OncoTyrol is to harness the benefits of the molecular revolution in cancer medicine by translating genomic, proteomic and metabolomic research into innovative, individualized and cost-effective approaches for cancer prevention, diagnosis and treatment. The consortium of researchers at the Biomedical Campus Innsbruck, which is close to three local universities and the University Hospital Innsbruck, together with national and international academic and industrial partners has joined efforts to develop and feed a pipeline of basic, translational, clinical and decision-analytic cancer research, and consequently establish a European center of excellence in cancer research with strong international visibility and an outstanding reputation. Due to the substantial scientific strengths and clinical expertise in breast and prostate cancer, chronic myeloid and lymphocytic leukemia, these paradigm malignancies were chosen as the primary targets of research. OncoTyrol research is supported by core facilities, which include technology platforms for genomic, epigenomic and proteomic profiling, SNP analysis and flow cytometry, a bioinformatics unit, tissue and serum banks, animal testing facilities and a clinical trial center within a comprehensive cancer center. *

	Start	2011-05-03 existent
	Industry	science

	Region	Innsbruck
	Country	Austria
	Street	5 Karl-Kapferer-Str.
	City	6020 Innsbruck
	Tel	+43-512-576523-0
	Fax	+43-512-576523-301
		Address record changed: 2011-05-03

Basic data	Employees	n. a.

		* Document for »About Section«: Protagen AG. (6/10/09). "Press Release: Protagen and OncoTyrol Form Strategic Alliance to Validate the UNIarray Technology Platform". Dortmund & New Jersey.

		Record changed: 2012-04-05

Follow Us!

Top News

Upcoming Events

Associations

Partners

OncoTyrol – Center for Personalized Cancer Medicine GmbH

More documents for OncoTyrol – Center for Personalized Cancer Medicine GmbH